Clinical trial
Circulating Ghrelin as a Biomarker for Dementia
NCT05381090 is registered in ClinicalTrials.gov with Swansea University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Ghrelin as a Biomarker for Dementia
- Lead sponsor
- Swansea University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 15, 2022
- Completion date
- March 31, 2026
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.